Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial

Ähnliche Einträge

• Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial
  von: Potthoff, Karin, et al.
  Veröffentlicht: (2016)
• Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer; immunochemo and radiotherapy with erbitux); a multicenter phase IV trial
  Veröffentlicht: (2013)
• EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
  von: Zhou, Jiefu, et al.
  Veröffentlicht: (2025)
• IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer
  von: Zwicker, Felix, et al.
  Veröffentlicht: (2011)
• Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
  von: Habl, Gregor, et al.
  Veröffentlicht: (2010)